Noble Wealth Management PBC’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8
Closed -$1.25K – 849
2026
Q2
$1.25K Buy
+8
New +$1.2K ﹤0.01% 664

Other funds holding NVS

Noble Wealth Management PBC's NVS Position: Q3 2026 in Review

Noble Wealth Management PBC sold out of Novartis (NVS) in Q3 2026, closing a stake of 8 shares — an estimated $1.25K sold.

Noble Wealth Management PBC first reported a position in NVS in Q2 2026 and held it in 1 quarter. The position peaked at $1.25K in Q2 2026. 83 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Noble Wealth Management PBC reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
  • Noble Wealth Management PBC sold 8 Novartis shares in Q3 2026, an estimated $1.25K.
  • Noble Wealth Management PBC first reported a position in Novartis in Q2 2026 and held it in 1 quarter.
  • Noble Wealth Management PBC's Novartis position peaked at $1.25K in Q2 2026.
  • 83 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Noble Wealth Management PBC's 13F filing for Q3 2026, filed 1 Oct 2026.